Marker Therapeutics, Inc. (MRKR)
1.50
+0.11
(+7.91%)
USD |
NASDAQ |
Aug 24, 16:00
1.50
0.00 (0.00%)
After-Hours: 20:00
Marker Therapeutics Shareholders Equity (Quarterly) : 12.17M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 12.17M |
| March 31, 2026 | 13.80M |
| December 31, 2025 | 16.80M |
| September 30, 2025 | 18.39M |
| June 30, 2025 | 10.49M |
| March 31, 2025 | 14.49M |
| December 31, 2024 | 18.56M |
| September 30, 2024 | 7.450M |
| June 30, 2024 | 9.703M |
| March 31, 2024 | 11.79M |
| December 31, 2023 | 14.05M |
| September 30, 2023 | 16.71M |
| June 30, 2023 | 19.03M |
| March 31, 2023 | 15.91M |
| December 31, 2022 | 19.60M |
| September 30, 2022 | 22.60M |
| June 30, 2022 | 28.03M |
| March 31, 2022 | 35.71M |
| December 31, 2021 | 43.99M |
| September 30, 2021 | 52.28M |
| June 30, 2021 | 63.24M |
| March 31, 2021 | 72.49M |
| December 31, 2020 | 27.34M |
| September 30, 2020 | 30.60M |
| June 30, 2020 | 34.51M |
| Date | Value |
|---|---|
| March 31, 2020 | 39.50M |
| December 31, 2019 | 44.09M |
| September 30, 2019 | 47.88M |
| June 30, 2019 | 51.40M |
| March 31, 2019 | 55.61M |
| December 31, 2018 | 59.34M |
| September 30, 2018 | 0.6905M |
| June 30, 2018 | 4.144M |
| March 31, 2018 | 0.616M |
| December 31, 2017 | 3.658M |
| September 30, 2017 | 5.936M |
| June 30, 2017 | 8.566M |
| March 31, 2017 | 4.141M |
| December 31, 2016 | 6.185M |
| September 30, 2016 | 7.494M |
| June 30, 2016 | -19.33M |
| March 31, 2016 | -25.70M |
| December 31, 2015 | -21.36M |
| September 30, 2015 | -2.621M |
| June 30, 2015 | -9.813M |
| March 31, 2015 | -1.766M |
| December 31, 2014 | -1.024M |
| September 30, 2014 | -0.6562M |
| June 30, 2014 | -2.563M |
| March 31, 2014 | -5.506M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.359B |
| Tenaya Therapeutics, Inc. | 69.41M |
| Ironwood Pharmaceuticals, Inc. | -161.84M |
| Vericel Corp. | 370.04M |
| SELLAS Life Sciences Group, Inc. | 137.66M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 14.59M |
| Total Liabilities (Quarterly) | 2.42M |
| Current Ratio | 6.027 |